By Deep Shukla on January 28, 2024 Medical News Today Despite the debilitating nature of long COVID, there is an absence of diagnostic tests and therapeutic tools for long COVID. A new study…[...]
Read More
Scientists say that drugs that calm a key part of the immune system should be studied in clinical trials as potential long Covid treatments. Long Covid impacts some adults’ blood…[...]
Read More
JAN 2024 Authored by Amie Dahnke The Epoch Times Just how was the COVID-19 coronavirus so successful? The question has eluded scientists and medical professionals since the novel virus swept…[...]
Read More
FRIDAY, FEB 23, 2024 - Authored by Marina Zhang via The Epoch Times (emphasis ours), Between 2013 and 2021, rates of immunosuppression in adults have doubled, according to estimates from a…[...]
Read More
JAN 27, 2024 Authored by Amie Dahnke via The Epoch Times Just how was the COVID-19 coronavirus so successful? The question has eluded scientists and medical professionals since the novel…[...]
Read More
Hannah E. Davis, , Lisa McCorkell, Julia Moore Vogel, Eric J. Topol Nature Reviews Microbiology volume 21, pages133–146 (2023)Cite this article Abstract Long COVID is an often debilitating illness that occurs in at least 10% of…[...]
Read More
By Elizabeth Cooney Jan. 24, 2024 Reprints You’ve heard of long Covid, a condition in which the acute infection subsides but troubling symptoms persist. Less well known is chronic Covid: The virus…[...]
Read More
By Brenda Goodman, CNN August 28, 2023 Experts say it’s less risky to catch Covid-19 than it used to be, but there are still good reasons not to treat it casually. Daly…[...]
Read More
Research suggests that long-term smell loss is linked to an ongoing immune response in the nose By DUKE HEALTH NEWS OFFICE Research This article is part of Harvard Medical School’s continuing coverage of…[...]
Read More
DEC 15, 2023 - Authored by Marina Zhang via The Epoch Times There may be around a 1 in 10 chance that Pfizer mRNA COVID-19 vaccines will not generate spike…[...]
Read More